Loading...
•
Mar 31, 2023
Pediatrix Q1 2023 Earnings Report
Pediatrix reported first quarter earnings, with revenue in line with expectations and reflecting improvements in revenue cycle management operations.
Key Takeaways
Pediatrix Medical Group reported first quarter earnings with a net revenue of $491 million and an Adjusted EBITDA of $40 million. The company's EPS was $0.17, and the non-GAAP Adjusted EPS was $0.23.
Net revenue for the first quarter of 2023 was $491 million, compared to $482.2 million for the prior-year period.
Overall same-unit revenue increased by 2.0 percent, slightly offset by the impact of net acquisition activity.
Income from continuing operations was $14 million, or $0.17 per diluted share.
Adjusted EBITDA from continuing operations was $40.1 million, compared to $50.7 million for the prior-year period.
Forward Guidance
Pediatrix anticipates that its 2023 Adjusted EBITDA will be in a range of $235 million to $245 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...